Combining immunomodulators and antivirals for COVID-19 - Authors' reply.

Almansa, Raquel; Tedim, Ana P; de la Fuente, Amanda; Eiros, Jose María; Kelvin, David J; Torres, Antoni; Bermejo-Martin, Jesus F

Almansa, Raquel; Tedim, Ana P; de la Fuente, Amanda; Eiros, Jose María; Kelvin, David J; Torres, Antoni; Bermejo-Martin, Jesus F.

Almansa R; Group for Biomedical Research in Sepsis, Instituto de Investigación Biomédica de Salamanca, Gerencia Regional de Salud, Paseo de San Vicente, 37007 Salamanca, Spain.
Tedim AP; Research Unit, Hospital Universitario Río Hortega, Gerencia Regional de Salud, Valladolid, Spain.
de la Fuente A; Centro de Investigación Biomédica en Red en Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.
Eiros JM; Group for Biomedical Research in Sepsis, Instituto de Investigación Biomédica de Salamanca, Gerencia Regional de Salud, Paseo de San Vicente, 37007 Salamanca, Spain.
Kelvin DJ; Research Unit, Hospital Universitario Río Hortega, Gerencia Regional de Salud, Valladolid, Spain.
Torres A; Group for Biomedical Research in Sepsis, Instituto de Investigación Biomédica de Salamanca, Gerencia Regional de Salud, Paseo de San Vicente, 37007 Salamanca, Spain.
Bermejo-Martin JF; Research Unit, Hospital Universitario Río Hortega, Gerencia Regional de Salud, Valladolid, Spain.

Lancet Microbe ; 2(6): e234, 2021 06.

Article in English | MEDLINE | ID: covidwho-1253812

Subject(s)

COVID-19 Drug Treatment; Dermatologic Agents; Adjuvants, Immunologic; Antiviral Agents/therapeutic use; Humans; Immunologic Factors/therapeutic use; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Dermatologic Agents / COVID-19 Drug Treatment Limits: Humans Language: English Journal: Lancet Microbe Year: 2021 Document Type: Article Affiliation country: S2666-5247(21)00115-4

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google